Kawakawa — Hermetica Encyclopedia
Herb · Pacific Islands

Kawakawa (Piper excelsum)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Kawakawa contains amide alkaloids including piperdardine and piperine, alongside lignans, phenylpropanoids such as myristicin, and flavonoids including vitexin, which collectively modulate glucose uptake in enterocytes, inhibit pro-inflammatory cytokines, and alter postprandial microRNA expression. In Caco-2 enterocyte models, piperdardine increased cellular glucose uptake by 83 ± 18% at 100 μM, and myristicin suppressed nitric oxide, IL-6, and IL-10 production in macrophage and monocyte cell lines.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordkawakawa benefits
Kawakawa close-up macro showing natural texture and detail — rich in digestive, gut, metabolism
Kawakawa — botanical close-up

Health Benefits

**Digestive Support**
Traditional Māori use of kawakawa as an aqueous infusion (tea) for digestive ailments is supported by the presence of piperine-related amide alkaloids, which influence intestinal nutrient uptake and may modulate gut motility through enteric nerve pathways.
**Glucose Metabolism Modulation**
Piperdardine, an amide constituent of kawakawa, increased glucose uptake by 83 ± 18% in Caco-2 enterocyte-like cells at 100 μM, suggesting a potential role in supporting healthy postprandial glucose handling through amide-mediated transporter activity.
**Anti-inflammatory Activity**
Myristicin inhibits the production of pro-inflammatory mediators including nitric oxide, IL-6, and IL-10 in mouse macrophage and THP-1 monocyte models, indicating capacity to dampen classical innate immune inflammatory cascades.
**Skin Health (Topical Use)**
Māori traditional medicine employed kawakawa topically for skin conditions, with lignans such as (+)-excelsin and (+)-diayangambin contributing probable antioxidant and anti-inflammatory effects at the skin surface.
**MicroRNA and Postprandial Gene Regulation**
Human consumption of kawakawa infusion altered postprandial microRNA profiles, including upregulation of hsa-miR-17-5p, -21-5p, -320a-5p, let-7g-5p, -16-5p, -122-5p, and -144-3p and downregulation of hsa-miR-221-3p and -223-3p, suggesting systemic gene expression modulation beyond local gastrointestinal effects.
**Antioxidant Activity**
The flavonoids vitexin and isovitexin, alongside phenylpropanoids elemicin and myristicin, contribute to free radical scavenging capacity, which may underpin both the anti-inflammatory and skin-protective properties observed in traditional use.
**Bioavailable Phytochemical Delivery**
Multiple kawakawa compounds have been confirmed to be bioavailable and subject to phase 1 and phase 2 hepatic and intestinal metabolism, indicating that active constituents from traditional tea preparations reach systemic circulation in pharmacologically meaningful forms.

Origin & History

Kawakawa growing in New Zealand — natural habitat
Natural habitat

Piper excelsum, commonly known as kawakawa, is a shrub endemic to New Zealand (Aotearoa) and is widespread throughout the country's coastal and lowland forests, particularly in the North Island. It thrives in warm, humid environments with partial shade, growing as an understory plant beneath native forest canopy. Kawakawa holds deep significance to Māori as a taonga (treasured) plant and has been cultivated and harvested from wild populations for centuries.

Kawakawa (Piper excelsum) is one of the most culturally significant plants in Māori tradition, regarded as a taonga (treasure) and used extensively in rongoā Māori, the indigenous medicine system of New Zealand. Traditionally, kawakawa leaves were prepared as an aqueous infusion to treat digestive complaints, urinary disorders, and skin conditions, and were also applied topically as poultices to wounds and inflammatory skin lesions. The plant holds deep ceremonial importance — kawakawa garlands (pare kawakawa) are worn at tangihanga (funerals) and other significant gatherings as symbols of mourning and respect for the deceased. The characteristic insect-eaten holes in kawakawa leaves are traditionally valued as a sign of the plant's potency, reflecting its role as a host for the native looper moth caterpillar (Cleora scriptaria), and leaves with holes are often preferentially selected for ceremonial and medicinal use.Traditional Medicine

Scientific Research

The current evidence base for Piper excelsum is limited and consists predominantly of in vitro mechanistic studies and preliminary human biomarker research rather than powered randomized controlled trials. In vitro work using Caco-2 cell models has quantified the glucose uptake effects of individual amide constituents such as piperdardine, while separate macrophage and monocyte assays have characterized the anti-inflammatory properties of myristicin. A human intervention study investigating postprandial microRNA expression following kawakawa consumption has been conducted, though detailed sample sizes and full statistical effect sizes have not been comprehensively published in accessible literature as of the available evidence. One phytochemical profiling study identified 64 compounds across fresh and dried leaf preparations and confirmed systemic bioavailability of multiple constituents, but no large-scale randomized controlled trials assessing clinical endpoints such as glycemic control, inflammatory biomarkers, or dermatological outcomes in human populations have been reported.

Preparation & Dosage

Kawakawa steeped as herbal tea — pairs with Kawakawa's piperine-class amides share structural and functional overlap with black pepper (Piper nigrum) piperine, which is well-established as a bioavailability enhancer for curcumin and other polyphenols via inhibition of CYP3A4 and P-glycoprotein efflux; combining kawakawa preparations with turmeric (Curcuma longa) may therefore produce additive bioavailability enhancement. The anti-inflammatory action of kawakawa myristicin
Traditional preparation
**Traditional Aqueous Infusion (Tea)**
Fresh or dried kawakawa leaves steeped in boiling water; no standardized dose established, but traditional Māori use involved moderate daily consumption; concentrations from this method remain below documented toxicity thresholds.
**Dried Leaf Powder**
Commercially available dried kawakawa leaves show higher concentrations of phenylpropanoids and flavonoids compared to fresh field-collected leaves; specific standardized dosage not yet defined by clinical trials.
**Methanolic/Ethanolic Extract**
Used in research settings to characterize bioactive profiles; not currently standardized for commercial supplement use.
**Topical Preparations**
Leaves were traditionally crushed or poulticed and applied directly to skin lesions and inflammatory conditions; no standardized topical extract concentration established.
**Culinary Seasoning**
Novel use as a food seasoning with dried ground leaf; metabolite concentrations from this application have been assessed as below toxicity thresholds.
**Dosage Note**
No clinically validated effective dose range has been established for any health indication; dosing guidance derives exclusively from traditional practice and general phytochemical safety profiling.

Nutritional Profile

Kawakawa leaves contain a complex phytochemical matrix of 64 identified compounds across multiple chemical classes. Amide alkaloids including piperine, pellitorine, dihydropiperlonguminine, fagaramide, piperdardine, and chingchengenamide A are more concentrated in fresh field-collected leaves. Lignans including (+)-diayangambin, (+)-excelsin, (+)-diasesartemin, (+)-sesartemin, and episesartemin A and B are present in significant quantities in fresh material. Phenylpropanoids myristicin and elemicin, the flavonoids vitexin and isovitexin, and the monoterpenoid α-pinene contribute to the volatile and non-volatile phytochemical profile. Dried commercial leaves show relatively higher phenylpropanoid and flavonoid concentrations. Specific quantitative concentration data (mg/g) for individual constituents in standardized preparations has not been fully published in accessible literature. Bioavailability of multiple constituents is confirmed with phase 1 and phase 2 metabolic transformation documented in vivo.

How It Works

Mechanism of Action

Piperdardine and related piperine-class amides interact with intestinal glucose transport mechanisms, with the amide functional group appearing critical for stimulating glucose uptake in Caco-2 enterocyte models, likely through modulation of SGLT1 or GLUT2 transporter activity. Myristicin suppresses NF-κB-dependent transcription of pro-inflammatory cytokines including nitric oxide synthase (iNOS), IL-6, and IL-10 in activated macrophages and THP-1 monocytes, dampening the classical innate inflammatory response. Lignans such as (+)-excelsin and (+)-diasesartemin may contribute antioxidant effects via direct radical scavenging and possible modulation of Nrf2 antioxidant response element pathways. At the epigenomic level, kawakawa consumption in humans altered the abundance of nine microRNAs postprandially, including upregulation of the oncomiR hsa-miR-21-5p and metabolic regulator hsa-miR-122-5p, suggesting broad downstream regulation of lipid metabolism, inflammatory signaling, and cellular stress response genes.

Clinical Evidence

Clinical investigation of kawakawa remains at an early stage, with no published large randomized controlled trials establishing efficacy for digestive or skin health endpoints. The most substantive human data derives from a preliminary intervention study examining postprandial microRNA expression changes, which demonstrated differential regulation of nine miRNAs following kawakawa tea consumption, but full statistical methodology and sample size details are not comprehensively published. In vitro data from Caco-2 enterocyte models provides mechanistically plausible support for glucose uptake effects (83 ± 18% increase with piperdardine at 100 μM), but translation to clinically relevant in vivo doses has not been established. Overall confidence in clinical efficacy claims remains low due to the absence of adequately powered human trials, and current evidence supports only traditional and exploratory use designations.

Safety & Interactions

Based on available evidence, concentrations of pharmacologically active metabolites delivered by traditional aqueous infusion or use as a culinary seasoning are well below documented toxicity thresholds, supporting a favorable short-term safety profile at customary consumption levels. No specific adverse effects, drug interactions, or contraindications have been formally documented in clinical studies, likely reflecting the limited volume of human research rather than confirmed safety across all populations. Given the presence of myristicin, a compound shared with nutmeg (Myristica fragrans) and known to carry neurotoxic risk at high doses, excessive concentrated extract consumption should be approached with caution. Guidance for use during pregnancy and lactation cannot be provided due to absence of relevant safety data, and conventional medical advice recommends avoiding unstudied herbal preparations during these periods; individuals taking anticoagulants, antiplatelet drugs, or hypoglycemic medications should exercise caution given the demonstrated effects on glucose uptake and the theoretical interactions of piperine-class compounds with cytochrome P450 drug metabolism enzymes.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Piper excelsumKawakawaNew Zealand pepper treeMacropiper excelsumPepper tree (NZ)

Frequently Asked Questions

What is kawakawa used for in traditional Māori medicine?
In rongoā Māori, kawakawa (Piper excelsum) was primarily used as an aqueous infusion to treat digestive complaints, urinary disorders, and toothache, and topically as a leaf poultice for inflammatory skin conditions and wounds. The plant also carries deep ceremonial significance, with garlands worn at funerals as symbols of mourning. Its medicinal use is supported by the presence of anti-inflammatory amide alkaloids, lignans, and phenylpropanoids in the leaf tissue.
What are the main active compounds in kawakawa?
Kawakawa contains 64 identified phytochemical compounds including piperine-class amide alkaloids (piperine, pellitorine, piperdardine), lignans ((+)-diayangambin, (+)-excelsin), phenylpropanoids (myristicin, elemicin), flavonoids (vitexin, isovitexin), and the terpenoid α-pinene. Fresh field-collected leaves tend to be richer in amides and lignans, while commercially dried leaves show higher concentrations of phenylpropanoids and flavonoids. Multiple compounds have been confirmed to be bioavailable and metabolically processed following consumption.
Does kawakawa help with blood sugar or glucose metabolism?
In vitro research using Caco-2 enterocyte-like cells found that piperdardine, an amide constituent of kawakawa, increased glucose uptake by 83 ± 18% at a concentration of 100 μM compared to control cells, with the amide functional group identified as critical for this effect. However, these findings are from cell culture models and have not been replicated in human clinical trials, so kawakawa cannot currently be recommended as a validated intervention for blood sugar management. The traditional use context also does not specifically target glycemic control.
Is kawakawa tea safe to drink daily?
Based on available phytochemical safety assessments, the concentrations of active metabolites delivered through traditional aqueous infusion at customary preparation strengths are well below documented toxicity thresholds. However, formal human safety trials with daily dosing protocols have not been conducted, and individuals taking medications metabolized by CYP3A4 enzymes (such as certain anticoagulants or statins) should exercise caution due to the potential piperine-class inhibitory effects on drug metabolism. Pregnant or breastfeeding individuals are advised to consult a healthcare provider before use given the absence of reproductive safety data.
How does kawakawa compare to black pepper (Piper nigrum)?
Kawakawa (Piper excelsum) and black pepper (Piper nigrum) are both members of the Piperaceae family and share several amide alkaloids including piperine, which contributes similar mechanisms of action in intestinal nutrient uptake modulation and potential bioavailability enhancement of co-administered compounds. However, kawakawa has a broader and more diverse phytochemical profile including unique lignans like (+)-excelsin and (+)-diayangambin not prominent in black pepper, and differs in its flavonoid and phenylpropanoid composition. Black pepper has a substantially larger clinical evidence base, while kawakawa research remains primarily at the in vitro and preliminary human biomarker stage.
What is the most effective form of kawakawa for digestive support—fresh leaf, dried tea, or extract?
Traditional aqueous infusions (tea) of dried kawakawa leaf remain the most studied and effective form for digestive support, as the hot water extraction optimally dissolves the piperine-related amide alkaloids responsible for modulating gut motility and intestinal nutrient uptake. Dried leaf tea allows for standardized preparation and consistent dosing of active compounds, while concentrated extracts may alter the bioavailability profile compared to whole-plant preparations used in Māori medicine. Fresh leaf preparations are less stable and may lose potency quickly, making dried tea the most practical option for regular use.
Is kawakawa safe to take with blood sugar medications or diabetes treatments?
Kawakawa should be used cautiously alongside blood sugar medications, as evidence suggests its piperdardine content may enhance glucose uptake and modulate glucose metabolism, potentially amplifying drug effects. Anyone taking antidiabetic medications (metformin, sulfonylureas, or insulin) should consult a healthcare provider before adding kawakawa supplements, as concurrent use may increase hypoglycemia risk. Medical supervision is essential to monitor blood glucose levels and adjust medication dosing if kawakawa is introduced.
What does current clinical research show about kawakawa's efficacy for digestive complaints compared to traditional use?
While kawakawa has a long traditional use history in Māori medicine for digestive ailments, robust human clinical trials specifically evaluating digestive outcomes remain limited; most mechanistic evidence comes from in vitro and animal studies demonstrating the piperine-amide alkaloids' effects on intestinal motility and nutrient absorption. The available research supports the chemical plausibility of traditional digestive applications, but large-scale randomized controlled trials in human populations are needed to quantify efficacy and establish optimal dosing protocols. Current evidence is stronger for the ingredient's chemical composition and mechanism than for definitive clinical efficacy in humans.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.